<DOC>
	<DOCNO>NCT01660620</DOCNO>
	<brief_summary>We hypothesize topical betaxolol reduce development severe retinopathy prematurity .</brief_summary>
	<brief_title>Topical Betaxolol Prevention Retinopathy Prematurity</brief_title>
	<detailed_description>The drug administer twice day 32 35 week gestational age , ime ROP likely arise .</detailed_description>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Retinopathy Prematurity</mesh_term>
	<mesh_term>Betaxolol</mesh_term>
	<criteria>&lt; 1251 grms birth weight ocular defect</criteria>
	<gender>All</gender>
	<minimum_age>32 Weeks</minimum_age>
	<maximum_age>32 Weeks</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>betaxolol/ retinopathy prematurity</keyword>
</DOC>